BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 29351359)

  • 1. CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.
    Zhao G; Huang BL; Rigueur D; Wang W; Bhoot C; Charles KR; Baek J; Mohan S; Jiang J; Lyons KM
    J Bone Miner Res; 2018 Jun; 33(6):1076-1089. PubMed ID: 29351359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN1/Cyr61 Is Required in Osteoblasts for Responsiveness to the Anabolic Activity of PTH.
    Zhao G; Kim EW; Jiang J; Bhoot C; Charles KR; Baek J; Mohan S; Adams JS; Tetradis S; Lyons KM
    J Bone Miner Res; 2020 Nov; 35(11):2289-2300. PubMed ID: 32634285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted disruption of BMP signaling through type IA receptor (BMPR1A) in osteocyte suppresses SOST and RANKL, leading to dramatic increase in bone mass, bone mineral density and mechanical strength.
    Kamiya N; Shuxian L; Yamaguchi R; Phipps M; Aruwajoye O; Adapala NS; Yuan H; Kim HK; Feng JQ
    Bone; 2016 Oct; 91():53-63. PubMed ID: 27402532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading.
    Moriishi T; Fukuyama R; Ito M; Miyazaki T; Maeno T; Kawai Y; Komori H; Komori T
    PLoS One; 2012; 7(6):e40143. PubMed ID: 22768243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
    Yee CS; Manilay JO; Chang JC; Hum NR; Murugesh DK; Bajwa J; Mendez ME; Economides AE; Horan DJ; Robling AG; Loots GG
    J Bone Miner Res; 2018 Oct; 33(10):1748-1759. PubMed ID: 29750826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYR61/CCN1 stimulates proliferation and differentiation of osteoblasts in vitro and contributes to bone remodeling in vivo in myeloma bone disease.
    Liu H; Peng F; Liu Z; Jiang F; Li L; Gao S; Wang G; Song J; Ruan E; Shao Z; Fu R
    Int J Oncol; 2017 Feb; 50(2):631-639. PubMed ID: 28035364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor α in osteocytes regulates trabecular bone formation in female mice.
    Kondoh S; Inoue K; Igarashi K; Sugizaki H; Shirode-Fukuda Y; Inoue E; Yu T; Takeuchi JK; Kanno J; Bonewald LF; Imai Y
    Bone; 2014 Mar; 60():68-77. PubMed ID: 24333171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resorption controls bone anabolism driven by parathyroid hormone (PTH) receptor signaling in osteocytes.
    Rhee Y; Lee EY; Lezcano V; Ronda AC; Condon KW; Allen MR; Plotkin LI; Bellido T
    J Biol Chem; 2013 Oct; 288(41):29809-20. PubMed ID: 23963454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells.
    Si W; Kang Q; Luu HH; Park JK; Luo Q; Song WX; Jiang W; Luo X; Li X; Yin H; Montag AG; Haydon RC; He TC
    Mol Cell Biol; 2006 Apr; 26(8):2955-64. PubMed ID: 16581771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
    Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
    Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-derived sclerostin and Wnt/β-catenin signaling regulate PDGFRα
    Kim SP; Da H; Wang L; Taketo MM; Wan M; Riddle RC
    FASEB J; 2021 Nov; 35(11):e21957. PubMed ID: 34606641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor.
    Delgado-Calle J; Tu X; Pacheco-Costa R; McAndrews K; Edwards R; Pellegrini GG; Kuhlenschmidt K; Olivos N; Robling A; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2017 Mar; 32(3):522-535. PubMed ID: 27704638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/Sclerostin.
    Sato AY; Cregor M; Delgado-Calle J; Condon KW; Allen MR; Peacock M; Plotkin LI; Bellido T
    J Bone Miner Res; 2016 Oct; 31(10):1791-1802. PubMed ID: 27163932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Gsα in osteocytes leads to osteopenia due to sclerostin induced suppression of osteoblast activity.
    Fulzele K; Dedic C; Lai F; Bouxsein M; Lotinun S; Baron R; Divieti Pajevic P
    Bone; 2018 Dec; 117():138-148. PubMed ID: 30266511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerostin binds and regulates the activity of cysteine-rich protein 61.
    Craig TA; Bhattacharya R; Mukhopadhyay D; Kumar R
    Biochem Biophys Res Commun; 2010 Jan; 392(1):36-40. PubMed ID: 20043874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone.
    Tu X; Delgado-Calle J; Condon KW; Maycas M; Zhang H; Carlesso N; Taketo MM; Burr DB; Plotkin LI; Bellido T
    Proc Natl Acad Sci U S A; 2015 Feb; 112(5):E478-86. PubMed ID: 25605937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling.
    Rhee Y; Allen MR; Condon K; Lezcano V; Ronda AC; Galli C; Olivos N; Passeri G; O'Brien CA; Bivi N; Plotkin LI; Bellido T
    J Bone Miner Res; 2011 May; 26(5):1035-46. PubMed ID: 21140374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss.
    Baroi S; Czernik PJ; Chougule A; Griffin PR; Lecka-Czernik B
    Bone; 2021 Jun; 147():115913. PubMed ID: 33722775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt Inhibitor Sclerostin Is Up-regulated by Mechanical Unloading in Osteocytes in Vitro.
    Spatz JM; Wein MN; Gooi JH; Qu Y; Garr JL; Liu S; Barry KJ; Uda Y; Lai F; Dedic C; Balcells-Camps M; Kronenberg HM; Babij P; Pajevic PD
    J Biol Chem; 2015 Jul; 290(27):16744-58. PubMed ID: 25953900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.